Published online Mar 31, 2019. doi: 10.13105/wjma.v7.i3.96
Peer-review started: February 12, 2019
First decision: March 20, 2019
Revised: March 27, 2019
Accepted: March 27, 2019
Article in press: March 28, 2019
Published online: March 31, 2019
Processing time: 50 Days and 23.3 Hours
This opinion review summarizes comparison of clinical presentation and immunology of post-endoscopic pancreatitis and acute pancreatitis (AP) of other etiology. The rationale for this topic was found in studies that mention differences in clinical presentation between these entities, stating that severe form of AP after endoscopic retrograde cholangiopancreatography was more severe than AP of other etiology. Found difference in clinical presentation may have a background in different immunology that needs to be further investigated.
Core tip: Innate immunity plays an immense role in the development of acute pancreatitis (AP) and may determine the course of the disease. Information about the role of innate immunity in patients with post-endoscopic pancreatitis (PEP) is still deficient. PEP may serve as an ideal model for further research of innate immunity function in AP development.
